Cyclization of Two Antimicrobial Peptides Improves Their Activity

Area of Science:

• Biochemistry
• Microbiology
• Materials Science

Background:

• Antimicrobial resistance is a global health crisis.
• Cyclic peptides offer enhanced stability and efficacy compared to linear counterparts.
• Understanding peptide-membrane interactions is crucial for developing new antibacterial agents.

Purpose of the Study:

• To evaluate the antibacterial effectiveness, stability, and toxicity of cyclic peptides CE-03 and CE-05.
• To compare the properties of cyclic peptides with their linear versions.
• To elucidate the mechanism of action of these peptides on bacterial and eukaryotic membranes.

Main Methods:

• Circular dichroism (CD) spectroscopy to determine peptide structures in model membranes.
• X-ray diffuse scattering (XDS) and Neutron Reflectometry (NR) to analyze peptide location and interaction with lipid model membranes (LMMs).
• Proteolytic degradation studies using elastase enzyme.

Main Results:

• CE-03 and CE-05 adopt random coil and β-sheet structures in bacterial and eukaryotic LMMs, exhibiting bactericidal activity.
• Peptides penetrate deeply into eukaryotic LMMs without toxicity but localize to the headgroup in bacterial LMMs, correlating with bacterial killing.
• CE-03 and CE-05 resist proteolytic degradation, retaining activity unlike a linear helical peptide.

Conclusions:

• Cyclic peptides CE-03 and CE-05 demonstrate significant potential as antibacterial agents due to their stability and targeted membrane disruption.
• Their distinct interaction mechanisms with bacterial versus eukaryotic membranes suggest a favorable safety profile.
• These findings support the development of cyclic peptides as a viable strategy to combat antimicrobial resistance.